Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

S100A6 stimulates proliferation and migration of colorectal carcinoma cells through activation of the MAPK pathways.

Duan L, Wu R, Zou Z, Wang H, Ye L, Li H, Yuan S, Li X, Zha H, Sun H, Zhang Y, Chen X, Zhou L.

Int J Oncol. 2014 Mar;44(3):781-90. doi: 10.3892/ijo.2013.2231. Epub 2013 Dec 30.

PMID:
24378749
2.

miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway.

Wang H, An H, Wang B, Liao Q, Li W, Jin X, Cui S, Zhang Y, Ding Y, Zhao L.

Eur J Cancer. 2013 Dec;49(18):3924-35. doi: 10.1016/j.ejca.2013.07.149. Epub 2013 Aug 19.

PMID:
23968734
3.

S100A6 promotes cell proliferation in human nasopharyngeal carcinoma via the p38/MAPK signaling pathway.

Li A, Shi D, Xu B, Wang J, Tang YL, Xiao W, Shen G, Deng W, Zhao C.

Mol Carcinog. 2017 Mar;56(3):972-984. doi: 10.1002/mc.22563. Epub 2016 Sep 27.

PMID:
27596819
4.

ST13, a proliferation regulator, inhibits growth and migration of colorectal cancer cell lines.

Bai R, Shi Z, Zhang JW, Li D, Zhu YL, Zheng S.

J Zhejiang Univ Sci B. 2012 Nov;13(11):884-93. doi: 10.1631/jzus.B1200037.

5.

SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.

Wong CC, Qian Y, Li X, Xu J, Kang W, Tong JH, To KF, Jin Y, Li W, Chen H, Go MY, Wu JL, Cheng KW, Ng SS, Sung JJ, Cai Z, Yu J.

Gastroenterology. 2016 Nov;151(5):945-960.e6. doi: 10.1053/j.gastro.2016.07.011. Epub 2016 Jul 21.

6.

HPIP is upregulated in colorectal cancer and regulates colorectal cancer cell proliferation, apoptosis and invasion.

Feng Y, Xu X, Zhang Y, Ding J, Wang Y, Zhang X, Wu Z, Kang L, Liang Y, Zhou L, Song S, Zhao K, Ye Q.

Sci Rep. 2015 Mar 24;5:9429. doi: 10.1038/srep09429.

7.

GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.

Wu J, Xie N, Xie K, Zeng J, Cheng L, Lei Y, Liu Y, Song L, Dong D, Chen Y, Zeng R, Nice EC, Huang C, Wei Y.

Carcinogenesis. 2013 Dec;34(12):2861-9. doi: 10.1093/carcin/bgt229. Epub 2013 Jun 26.

PMID:
23803691
8.

MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2.

Liang L, Li X, Zhang X, Lv Z, He G, Zhao W, Ren X, Li Y, Bian X, Liao W, Liu W, Yang G, Ding Y.

Gastroenterology. 2013 Mar;144(3):624-635.e4. doi: 10.1053/j.gastro.2012.11.033. Epub 2012 Nov 27.

PMID:
23201162
9.

The molecular chaperone Cosmc enhances malignant behaviors of colon cancer cells via activation of Akt and ERK.

Huang J, Che MI, Lin NY, Hung JS, Huang YT, Lin WC, Huang HC, Lee PH, Liang JT, Huang MC.

Mol Carcinog. 2014 Feb;53 Suppl 1:E62-71. doi: 10.1002/mc.22011. Epub 2013 Feb 6.

PMID:
23390052
10.

Overexpression of DNAJB6 promotes colorectal cancer cell invasion through an IQGAP1/ERK-dependent signaling pathway.

Zhang TT, Jiang YY, Shang L, Shi ZZ, Liang JW, Wang Z, Zhang Y, Hao JJ, Jia XM, Xu X, Cai Y, Zhan QM, Wang MR.

Mol Carcinog. 2015 Oct;54(10):1205-13. doi: 10.1002/mc.22194. Epub 2014 Jul 7.

PMID:
25044025
11.

Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer.

Chen DL, Wang DS, Wu WJ, Zeng ZL, Luo HY, Qiu MZ, Ren C, Zhang DS, Wang ZQ, Wang FH, Li YH, Kang TB, Xu RH.

Carcinogenesis. 2013 Apr;34(4):803-11. doi: 10.1093/carcin/bgs400. Epub 2012 Dec 28.

12.

Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer.

Li H, Dai S, Zhen T, Shi H, Zhang F, Yang Y, Kang L, Liang Y, Han A.

Eur J Cancer. 2014 Apr;50(6):1207-21. doi: 10.1016/j.ejca.2013.12.010. Epub 2014 Jan 9.

PMID:
24412052
13.

UHRF1 promotes cell growth and metastasis through repression of p16(ink⁴a) in colorectal cancer.

Wang F, Yang YZ, Shi CZ, Zhang P, Moyer MP, Zhang HZ, Zou Y, Qin HL.

Ann Surg Oncol. 2012 Aug;19(8):2753-62. doi: 10.1245/s10434-011-2194-1. Epub 2012 Jan 5.

PMID:
22219067
14.

S100A6 is transcriptionally regulated by β-catenin and interacts with a novel target, lamin A/C, in colorectal cancer cells.

Kilańczyk E, Graczyk A, Ostrowska H, Kasacka I, Leśniak W, Filipek A.

Cell Calcium. 2012 Jun;51(6):470-7. doi: 10.1016/j.ceca.2012.04.005. Epub 2012 May 4.

PMID:
22560296
15.

Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.

Meng X, Wu J, Pan C, Wang H, Ying X, Zhou Y, Yu H, Zuo Y, Pan Z, Liu RY, Huang W.

Gastroenterology. 2013 Aug;145(2):426-36.e1-6. doi: 10.1053/j.gastro.2013.04.004. Epub 2013 Apr 9.

PMID:
23583431
16.

JC virus mediates invasion and migration in colorectal metastasis.

Link A, Shin SK, Nagasaka T, Balaguer F, Koi M, Jung B, Boland CR, Goel A.

PLoS One. 2009 Dec 3;4(12):e8146. doi: 10.1371/journal.pone.0008146.

17.

The role of ERK2 in colorectal carcinogenesis is partly regulated by TRAPPC4.

Weng YR, Kong X, Yu YN, Wang YC, Hong J, Zhao SL, Fang JY.

Mol Carcinog. 2014 Feb;53 Suppl 1:E72-84. doi: 10.1002/mc.22031. Epub 2013 Apr 26.

PMID:
23625650
18.

Leptin-induced adhesion and invasion in colorectal cancer cell lines.

Yoon KW, Park SY, Kim JY, Lee SM, Park CH, Cho SB, Lee WS, Joo YE, Lee JH, Kim HS, Choi SK, Rew JS.

Oncol Rep. 2014 Jun;31(6):2493-8. doi: 10.3892/or.2014.3128. Epub 2014 Apr 3.

PMID:
24700392
19.

The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target.

Ohuchida K, Mizumoto K, Ishikawa N, Fujii K, Konomi H, Nagai E, Yamaguchi K, Tsuneyoshi M, Tanaka M.

Clin Cancer Res. 2005 Nov 1;11(21):7785-93.

20.

Knockdown of linc-POU3F3 suppresses the proliferation, apoptosis, and migration resistance of colorectal cancer.

Shan TD, Xu JH, Yu T, Li JY, Zhao LN, Ouyang H, Luo S, Lu XJ, Huang CZ, Lan QS, Zhong W, Chen QK.

Oncotarget. 2016 Jan 5;7(1):961-75. doi: 10.18632/oncotarget.5830.

Supplemental Content

Support Center